ciprofloxacin has been researched along with trans-4-coumaric acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, T; Chepkirui, C; Decock, C; Matasyoh, JC; Stadler, M | 1 |
| Ojha, D; Patil, KN | 1 |
2 other study(ies) available for ciprofloxacin and trans-4-coumaric acid
| Article | Year |
|---|---|
Sesquiterpenes from an Eastern African Medicinal Mushroom Belonging to the Genus Sanghuangporus.
Topics: Africa, Eastern; Agaricales; Anti-Infective Agents; Antibiotics, Antineoplastic; Bacteria; Basidiomycota; Cell Line, Tumor; Drug Screening Assays, Antitumor; Fermentation; Fungi; Humans; Kenya; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Sesquiterpenes; Tandem Mass Spectrometry | 2019 |
p-Coumaric acid inhibits the Listeria monocytogenes RecA protein functions and SOS response: An antimicrobial target.
Topics: Adenosine Triphosphate; Anti-Bacterial Agents; Ciprofloxacin; Coumaric Acids; DNA Repair; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Escherichia coli; Gene Expression; Hydrolysis; Listeria monocytogenes; Microbial Sensitivity Tests; Propionates; Rec A Recombinases; Recombination, Genetic; SOS Response, Genetics | 2019 |